Zalevsky Jonathan Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
25
Insider Sells Sum
$3.85M

Insider Activity of Zalevsky Jonathan

According to the SEC Form 4 filings, Zalevsky Jonathan, being in a position of

  1. Chief R&D Officer at Nektar Therapeutics,
    оver the last 12 months, has bought 0 shares, and sold 16808 shares for $974,185,
    over all time since 2019-11-18, has bought 0 shares, and sold 462104 shares for $4.92M.

Biography of Zalevsky Jonathan

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $974,1857100

Comparison of Insiders on Amount of Buys and Sells

2026-08-18SaleNektar Therapeutics
NKTR
Chief R&D Officer
186
0.0006%
$71.98$13,388-19.46%
2026-06-30SaleNektar Therapeutics
NKTR
Chief R&D Officer
5,681
0.0292%
$70.00$397,670-1.75%
2026-06-15SaleNektar Therapeutics
NKTR
Chief R&D Officer
5,538
0.0281%
$60.71$336,212+11.66%
2026-05-19SaleNektar Therapeutics
NKTR
Chief R&D Officer
199
0.001%
$65.51$13,036-1.35%
2026-02-18SaleNektar Therapeutics
NKTR
Chief R&D Officer
180
0.0009%
$73.00$13,140-3.54%
2026-01-20SaleNektar Therapeutics
NKTR
Chief R&D Officer
3,867
0.0187%
$35.67$137,936+91.8%
2025-11-25SaleNektar Therapeutics
NKTR
Chief R&D Officer
1,157
0.0057%
$54.28$62,802+11.65%
2025-09-04SaleNektar Therapeutics
NKTR
Chief R&D Officer
1,721
0.0084%
$33.52$57,693+80.39%
2025-09-02SaleNektar Therapeutics
NKTR
Chief R&D Officer
485
0.0026%
$30.10$14,599+122.89%
2025-08-19SaleNektar Therapeutics
NKTR
Chief R&D Officer
725
0.0038%
$26.59$19,278+131.21%
2025-05-19SaleNektar Therapeutics
NKTR
Chief R&D Officer
10,712
0.0055%
$0.67$7,177+478.7%
2025-02-19SaleNektar Therapeutics
NKTR
Chief R&D Officer
10,300
0.0053%
$1.01$10,403+82.87%
2024-12-19SaleNektar Therapeutics
NKTR
Chief R&D Officer
51,115
0.027%
$0.94$48,048+53.9%
2024-11-19SaleNektar Therapeutics
NKTR
Chief R&D Officer
7,785
0.0042%
$1.01$7,863-1.94%
2024-08-19SaleNektar Therapeutics
NKTR
Chief R&D Officer
6,866
0.0036%
$1.28$8,788-24.06%
2024-05-17SaleNektar Therapeutics
NKTR
Chief R&D Officer
7,355
0.0039%
$1.75$12,871-36.36%
2024-02-20SaleNektar Therapeutics
NKTR
Chief R&D Officer
9,014
0.0048%
$0.68$6,130+82.41%
2023-11-17SaleNektar Therapeutics
NKTR
Chief R&D Officer
9,646
0.0051%
$0.49$4,727+153.13%
2023-08-16SaleNektar Therapeutics
NKTR
Chief R&D Officer
9,703
0.0052%
$0.78$7,568-7.79%
2023-05-16SaleNektar Therapeutics
NKTR
Chief R&D Officer
9,791
0.0052%
$0.72$7,050-18.24%
Total: 36
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.